Loading company…
Nanjing Yuxi develops dermatological treatments and long-acting transdermal technology.
Established in 2020 and based in Nanjing, China, Nanjing Yuxi Pharmaceutical Technology develops solutions for dermatological diseases and a long-acting transdermal technology platform. Its product pipeline includes IDT-001. The company plans to fund research and development, clinical trials, platform development, and team building.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in